• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Athersys, Inc. (ATHX)

    -NasdaqCM
    2.09 Down 0.13(5.86%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:2.22
    Open:2.25
    Bid:2.05 x 500
    Ask:N/A
    1y Target Est:6.00
    Beta:0.16
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:2.08 - 2.25
    52wk Range:1.08 - 4.11
    Volume:418,405
    Avg Vol (3m):527,455
    Market Cap:162.01M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATHX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):74.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Dec-14) :-0.10
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which has Phase I... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback